Login / Signup

Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma.

Smith GiriSusan BalKelly N GodbyGayathri RaviDeanna ClarkClare UbersaxAbigail CooleyPriscila WhiteSunil RangarajanGrant R WilliamsLuciano José Megale Costa
Published in: American journal of hematology (2022)
Keyphrases
  • multiple myeloma
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • diffuse large b cell lymphoma
  • hodgkin lymphoma
  • stem cells